Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Mar 12;58(5):750-7.
doi: 10.1212/wnl.58.5.750.

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

C R Jack Jr  1 , D W Dickson, J E Parisi, Y C Xu, R H Cha, P C O'Brien, S D Edland, G E Smith, B F Boeve, E G Tangalos, E Kokmen, R C Petersen
Affiliations

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

C R Jack Jr et al. Neurology. .

Abstract

Objectives: To assess the diagnostic specificity of MRI-defined hippocampal atrophy for AD among individuals with a variety of pathologically confirmed conditions associated with dementia as well as changes attributable to typical aging, and to measure correlations among premortem MRI measurements of hippocampal atrophy, mental status examination performance, and the pathologic stage of AD.

Methods: An unselected series of 67 individuals participating in the Mayo Alzheimer's Disease Research Center/Alzheimer's Disease Patient Registry who had undergone a standardized antemortem MRI study and also postmortem examination were identified. Hippocampal volumes were measured from antemortem MRI. Each postmortem specimen was assigned a pathologic diagnosis and in addition, the severity of AD pathology was staged using the method of Braak and Braak.

Results: Individuals with an isolated pathologic diagnosis of AD, hippocampal sclerosis, frontotemporal degeneration, and neurofibrillary tangle--only degeneration usually had substantial hippocampal atrophy, while those with changes of typical aging did not. Among all 67 subjects, correlations (all p < 0.001) were observed between hippocampal volume and Braak and Braak stage (r = -0.39), between hippocampal volume and Mini-Mental State Examination (MMSE) score (r = 0.60), and between MMSE score and Braak and Braak stage (r = -0.41).

Conclusions: Hippocampal atrophy, while not specific for AD, was a fairly sensitive marker of the pathologic AD stage (particularly among subjects with isolated AD pathology [r = -0.63, p = 0.001]) and consequent cognitive status.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Braak's stage vs normalized bilateral hippocampal volume in isolated AD pathology subjects.
See this image and copyright information in PMC

References

    1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. - PubMed
    1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The national Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18:S1–S2. - PubMed
    1. de Leon MJ, Golomb J, Convit A, et al. Measurement of medial temporal lobe atrophy in diagnosis of Alzheimer's disease. The Lancet. 1993;341:125. - PubMed
    1. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 1996;119:2001–2007. - PubMed
    1. Jack CR, Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 1992;42:183–188. - PubMed

Publication types